NCT00778999View on ClinicalTrials.gov

Predictive Factors for Ovarian Stimulation Using a Fixed Daily Dose of 200 IU Recombinant FSH (Study 142003)(P05696)

PHASE4CompletedINTERVENTIONAL

Enrollment

442

Participants

Timeline

Start Date

October 1, 2006

Primary Completion Date

July 24, 2008

Study Completion Date

July 24, 2008

Conditions

Infertility

Interventions

DRUG

Marvelon

oral contraceptive 1 tablet daily for 14 to 21 days

All Listed Sponsors

lead

Organon and Co

INDUSTRY

NCT00778999 - Predictive Factors for Ovarian Stimulation Using a Fixed Daily Dose of 200 IU Recombinant FSH (Study 142003)(P05696) | Biotech Hunter | Biotech Hunter